Welcome to our dedicated page for Unitedhealth Gp SEC filings (Ticker: UNH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
UnitedHealth Group Incorporated filings document the formal disclosures of a large health care company organized around UnitedHealthcare and Optum. Proxy materials describe board governance, executive compensation, shareholder voting matters and the company’s complementary businesses: UnitedHealthcare health coverage and Optum clinical, data, product, pharmacy and care services.
Current reports on Form 8-K cover operating and financial results, Regulation FD communications, strategy and market-position discussions, director appointments, compensation arrangements and other material-event disclosures. The filing record also documents governance practices, capital-structure and compensation matters, risk-related business context and the regulatory reporting framework for a Delaware public operating company in the health care sector.
UnitedHealth Group Inc ownership disclosure: The Vanguard Group filed Amendment No. 11 to its Schedule 13G/A reporting that it beneficially owns 0 shares of Common Stock, representing 0%. The filing states this result follows an internal realignment effective January 12, 2026, under SEC Release No. 34-39538 (January 12, 1998), and that certain Vanguard subsidiaries now report holdings separately. The filing is signed by Ashley Grim, Head of Global Fund Administration, dated 03/27/2026.
UNITEDHEALTH GROUP INC director Valerie Montgomery Rice received 53 shares of Common Stock as a grant. The Form 4 shows this as a compensation-related acquisition, with no purchase price. The footnote explains these are dividend equivalents on vested deferred stock units, which are immediately vested and follow the same terms as the underlying units. After this grant, her directly held Common Stock totals 7,272 shares.
UNITEDHEALTH GROUP INC Chief Financial Officer Wayne S. DeVeydt reported an automatic stock-based award rather than a market trade. He acquired 149.989 shares of common stock at a stated price of $0.0000 per share, increasing his direct holdings to 19,666.93 shares.
According to the footnote, these shares represent dividend equivalents paid on outstanding restricted stock units. The dividend equivalents are subject to the same vesting terms as the underlying restricted stock units and will be forfeited if those units do not vest, making this a routine compensation-related accrual rather than an open-market purchase or sale.
UNITEDHEALTH GROUP INC Chief Accounting Officer Dennis Andrew Stankiewicz reported an acquisition of common stock tied to existing equity awards. On March 17, 2026, he received 68.058 shares of common stock at no cost as dividend equivalents on outstanding restricted stock units, which are subject to the same vesting conditions and are forfeited if the underlying units do not vest. Following this award, his directly held common stock position increased to 10,205.939 shares, indicating a routine compensation-related update rather than an open-market trade.
UnitedHealth Group director Paul R. Garcia received an equity-based award linked to existing deferred stock units. On March 17, 2026, he acquired 16 shares of common stock at $0.00 per share, described as dividend equivalents paid on vested deferred stock units that are immediately vested and subject to the same terms as the underlying units.
Following this grant, Garcia directly holds 3,330 shares of UnitedHealth Group common stock. He also has indirect holdings reported through a revocable trust and additional trusts, reflecting shares held in estate-planning vehicles rather than through open‑market transactions.
UNITEDHEALTH GROUP INC director John H. Noseworthy received 52 shares of common stock as a grant tied to dividend equivalents on vested deferred stock units. The shares were acquired at no cost, are immediately vested, and follow the same terms as the underlying deferred stock units. After this award, he directly holds 7,049 shares of common stock.
UNITEDHEALTH GROUP INC executive Christopher R. Zaetta received additional common stock linked to existing equity awards. On March 17, 2026, he acquired 89.629 shares of Common Stock at a stated price of $0.00 per share, reported as a grant or award acquisition.
The footnote explains this represents dividend equivalents paid on outstanding restricted stock units. These dividend equivalents follow the same vesting terms as the underlying restricted stock units and will be forfeited if those units do not vest. After this transaction, Zaetta directly holds 16,716.169 shares of Common Stock.
UNITEDHEALTH GROUP INC executive Timothy John Noel, Chief Executive Officer of UnitedHealthcare, received an acquisition of 102.329 shares of common stock as of March 17, 2026. These shares represent dividend equivalents on outstanding restricted stock units and are granted at no cash cost to him.
After this award, his directly held common stock position reported in this filing increased to 17,574.653 shares. The dividend equivalents are subject to the same vesting conditions as the underlying restricted stock units and will be forfeited if those units do not vest, making this a routine, compensation-related equity accrual rather than an open‑market purchase.
UNITEDHEALTH GROUP INC director Frederick William McNabb III reported an automatic share-based compensation event. He acquired 64 shares of common stock on March 17, 2026 with a reported price of $0.0000 per share, described as dividend equivalents on vested deferred stock units. These dividend equivalents are immediately vested and follow the same terms as the underlying deferred stock units. After this credit, his directly held common stock position increased to 14,774 shares, reflecting a small, routine adjustment rather than an open-market purchase.
UnitedHealth Group director Timothy Patrick Flynn reported a small stock award tied to existing deferred compensation. On March 17, 2026, he acquired 79 shares of UnitedHealth common stock at $0.0000 per share as dividend equivalents on vested deferred stock units, which are immediately vested and follow the same terms as the underlying units. Following this grant, his direct holdings total 10,239 shares of common stock, and he also holds 6,033 shares indirectly through a trust.